Clinical Trials Browser

Phase 2 × Random Allocation × Clear all

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Phase 2 Active not recruiting

36 enrolled 19 charts

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT02812641 2019-03-11

Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma